AksharChem India Q1FY27 Revenue at ₹140.87 Crore, Profit ₹15.21 Crore
AksharChem India reported Q1FY27 revenue of ₹140.87 crore and a profit after tax of ₹15.21 crore. This marks a significant increase from ₹96.96 crore revenue and ₹0.71 crore profit in Q1FY26. The results were approved by the Board on August 12, 2026.
The significant year-on-year growth in revenue and profit is a material event for investors and is likely to impact the company's stock price.
The company reported a substantial increase in revenue and profit for the quarter compared to the previous year, indicating strong financial performance.
AksharChem India Limited announced its unaudited financial results for the quarter ended June 30, 2026. The company's revenue from operations stood at ₹14,087.03 lakh (₹140.87 crore), a significant increase from ₹9,696.23 lakh (₹96.96 crore) in the corresponding quarter of the previous year.
Profit after tax for the quarter was ₹1,521.24 lakh (₹15.21 crore), a substantial improvement compared to a profit of ₹71.10 lakh (₹0.71 crore) in the quarter ended June 30, 2025. The company's total income for the quarter was ₹14,090.39 lakh (₹140.90 crore).
The Board of Directors approved these results in a meeting held on August 12, 2026, which commenced at 4:00 p.m. and concluded at 4:35 p.m. The financial results are also available on the company's website, www.aksharchemindia.com.
What to do with a filing like this
AksharChem India Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by AksharChem India Limited. Read the original for the full detail.